A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review
Related Experiment Video
Updated: Sep 29, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Jasjit S Suri1, Mrinalini Bhagawati2, Sudip Paul2
1Stroke Diagnostic and Monitoring Division, AtheroPoint™, Roseville, CA 95661, USA.
Insights
Artificial Intelligence (AI) methods show promise for cardiovascular disease (CVD) risk assessment. Careful selection of ground truth (GT) is crucial for AI models to prevent risk-of-bias (RoB) and ensure accurate CVD stratification.
Area of Science:
- Cardiology
- Artificial Intelligence
- Machine Learning
Background:
- Cardiovascular disease (CVD) is a leading global cause of mortality.
- Escalating healthcare costs necessitate early, non-invasive CVD risk assessment.
- Artificial Intelligence (AI) methods offer superior performance over conventional approaches for CVD risk prediction.
Purpose of the Study:
- To review the three most recent AI paradigms for CVD risk assessment: multiclass, multi-label, and ensemble-based methods.
- To analyze these methods in both office-based and stress-test laboratory settings.
- To evaluate AI risk-of-bias (RoB) within the CVD framework.
Main Methods:
- Systematic review of 265 CVD studies using PRISMA guidelines.
- Analysis of multiclass, multi-label, and ensemble AI methods using machine learning (ML) frameworks.
- Comprehensive review of AI methods based on architecture, applications, pros/cons, validation, and RoB.
Main Results:
- Office-based, laboratory-based, image-based phenotypes, and medication usage are common biomarkers.
- Surrogate carotid scanning shows promise for coronary artery risk prediction.
- Multiclass classification is the most popular paradigm, followed by ensemble and multi-label methods.
Conclusions:
- AI-based methods are highly promising for CVD risk assessment.
- Accurate ground truth (GT) selection is vital to prevent RoB in AI models.
- Combining image-based strategies with conventional risk factors enhances stability in AI CVD risk assessment frameworks.
Abstract:
Background and Motivation: Cardiovascular disease (CVD) causes the highest mortality globally. With escalating healthcare costs, early non-invasive CVD risk assessment is vital. Conventional methods have shown poor performance compared to more recent and fast-evolving Artificial Intelligence (AI) methods. The proposed study reviews the three most recent paradigms for CVD risk assessment, namely multiclass, multi-label, and ensemble-based methods in (i) office-based and (ii) stress-test laboratories. Methods: A total of 265 CVD-based studies were selected using the preferred reporting items for systematic reviews and meta-analyses (PRISMA) model. Due to its popularity and recent development, the study analyzed the above three paradigms using machine learning (ML) frameworks. We review comprehensively these three methods using attributes, such as architecture, applications, pro-and-cons, scientific validation, clinical evaluation, and AI risk-of-bias (RoB) in the CVD framework. These ML techniques were then extended under mobile and cloud-based infrastructure. Findings: Most popular biomarkers used were office-based, laboratory-based, image-based phenotypes, and medication usage. Surrogate carotid scanning for coronary artery risk prediction had shown promising results. Ground truth (GT) selection for AI-based training along with scientific and clinical validation is very important for CVD stratification to avoid RoB. It was observed that the most popular classification paradigm is multiclass followed by the ensemble, and multi-label. The use of deep learning techniques in CVD risk stratification is in a very early stage of development. Mobile and cloud-based AI technologies are more likely to be the future. Conclusions: AI-based methods for CVD risk assessment are most promising and successful. Choice of GT is most vital in AI-based models to prevent the RoB. The amalgamation of image-based strategies with conventional risk factors provides the highest stability when using the three CVD paradigms in non-cloud and cloud-based frameworks.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy I: Introduction and Classification
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
Classification of Systems-I
Homogeneity dictates that if an input x(t) is multiplied by a constant c, the output y(t) is multiplied by the same constant. Mathematically, this is expressed as:
Heart Failure IV: Classification and Diagnostic Evaluation